Compare ESSA Industries Indonesia Tbk. (ESSA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ESSA Industries Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? ESSA Industries Indonesia Tbk. trades at Rp655 (market cap 11.71T, 133.29M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: ESSA Industries Indonesia Tbk. is far larger — about 112.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ESSA | SCPI | |
|---|---|---|
Market Cap | 11.71T | 104.4B |
Volume | 133.29M | — |
Lot | 1.33M | — |
Turnover | 87.41B | — |
Average Price | 655.81 | — |
Value | 87.41B | — |
Indicative Equilibrium Price | 655 | — |
Indicative Equilibrium Volume | 55.53K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ESSA Industries Indonesia Tbk.
Surya Esa Perkasa, PT (the company) was established based on the Notarial Deed No. 7 dated March 24, 2006 of Hasbullah Abdul Rasyid SH., M.Kn, public notary in Jakarta, within the framework of Domestic Capital Law No. 6 year 1968 Jo Law No. 12 year 1970.
Read more on ESSA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
